CARsgen Issues Clarification, Adds Directors’ Responsibility Statement to 23.70 Million-Share Top-Up Placing Notice

Bulletin Express05-22

CARsgen Therapeutics Holdings Limited released a clarification announcement on 22 May 2026, amending its 15 May 2026 disclosure concerning the top-up placing and subscription of 23.70 million new shares.

The company confirmed that the only change to the original document is the inclusion of a formal responsibility statement. The board now explicitly “accepts full responsibility for the accuracy of the information” in the placing announcement and confirms that, after reasonable enquiry, the opinions expressed were made with due and careful consideration and that no material facts were omitted.

CARsgen reiterated that all other details of the 15 May transaction—covering the proposed issuance of 23.70 million shares—remain unchanged.

The board currently consists of executive directors Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang; non-executive directors Mr. Huaqing Guo and Mr. Ronggang Xie; and independent non-executive directors Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1163116464?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-22 21:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163116464","market":"us","top_or_hot":-1,"title":"CARsgen Issues Clarification, Adds Directors’ Responsibility Statement to 23.70 Million-Share Top-Up Placing Notice","media":"Bulletin Express","content":"<p>CARsgen Therapeutics Holdings Limited released a clarification announcement on 22 May 2026, amending its 15 May 2026 disclosure concerning the top-up placing and subscription of 23.70 million new shares.</p>\n<p>The company confirmed that the only change to the original document is the inclusion of a formal responsibility statement. The board now explicitly “accepts full responsibility for the accuracy of the information” in the placing announcement and confirms that, after reasonable enquiry, the opinions expressed were made with due and careful consideration and that no material facts were omitted.</p>\n<p>CARsgen reiterated that all other details of the 15 May transaction—covering the proposed issuance of 23.70 million shares—remain unchanged.</p>\n<p>The board currently consists of executive directors Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang; non-executive directors Mr. Huaqing Guo and Mr. Ronggang Xie; and independent non-executive directors Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CARsgen Issues Clarification, Adds Directors’ Responsibility Statement to 23.70 Million-Share Top-Up Placing Notice</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCARsgen Issues Clarification, Adds Directors’ Responsibility Statement to 23.70 Million-Share Top-Up Placing Notice\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-22 21:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CARsgen Therapeutics Holdings Limited released a clarification announcement on 22 May 2026, amending its 15 May 2026 disclosure concerning the top-up placing and subscription of 23.70 million new shares.</p>\n<p>The company confirmed that the only change to the original document is the inclusion of a formal responsibility statement. The board now explicitly “accepts full responsibility for the accuracy of the information” in the placing announcement and confirms that, after reasonable enquiry, the opinions expressed were made with due and careful consideration and that no material facts were omitted.</p>\n<p>CARsgen reiterated that all other details of the 15 May transaction—covering the proposed issuance of 23.70 million shares—remain unchanged.</p>\n<p>The board currently consists of executive directors Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang; non-executive directors Mr. Huaqing Guo and Mr. Ronggang Xie; and independent non-executive directors Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02171","symbol_name":"科济药业-B","start_time":0,"source_url":"","article_id":"1163116464","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163116464","pubTimestamp":1779456184,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"CARsgen Therapeutics Holdings Limited released a clarification announcement on 22 May 2026, amending its 15 May 2026 disclosure concerning the top-up placing and subscription of 23.70 million new...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02171":"科济药业-B"},"translate_title":"科济生物发出澄清，于2370万股先旧后新配售通告中加入董事责任声明","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"CARsgen Therapeutics Holdings Limited released a clarification announcement on 22 May 2026, amending its 15 May 2026 disclosure concerning the top-up placing and subscription of 23.70 million new shares.\nThe company confirmed that the only change to the original document is the inclusion of a formal responsibility statement. The board now explicitly “accepts full responsibility for the accuracy of the information” in the placing announcement and confirms that, after reasonable enquiry, the opinions expressed were made with due and careful consideration and that no material facts were omitted.\nCARsgen reiterated that all other details of the 15 May transaction—covering the proposed issuance of 23.70 million shares—remain unchanged.\nThe board currently consists of executive directors Dr. Zonghai Li, Dr. Huamao Wang and Dr. Hua Jiang; non-executive directors Mr. Huaqing Guo and Mr. Ronggang Xie; and independent non-executive directors Dr. Guangmei Yan, Ms. Xiangke Zhao and Dr. Wen Zhou.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1163116464","isCrawlerRequest":true}